Ars Pharmaceutica (Mar 2020)

Nanoparticles in the use of natural products for the treatment of lung cancer

  • Iago Dillion Lima Cavalcanti,
  • José Cleberson Santos Soares,
  • Wellington Francisco Pereira da Silva,
  • Beatriz Gomes Silva,
  • Ivone Antônia de Souza

DOI
https://doi.org/10.30827/ars.v60i3.9220
Journal volume & issue
Vol. 60, no. 3
pp. 185 – 192

Abstract

Read online

ABSTRACT Objective: Carry out a bibliographical survey about the use of nanoparticles in the delivery of natural products for the treatment of lung cancer. Methods: A bibliographic review was made using the descriptors “Nanoparticles”, “Biological Products” and “Lung Neoplasms”, through the databases ScienceDirect, PubMed and SciELO, in the period from 2009 to 2018. Results: After analyzing the articles according to the inclusion criteria, we obtained 31 articles, of which 25.81% refer to natural products in the treatment of lung cancer, 29.03% to nanoparticles in the treatment of lung cancer and 45.16 % to nanoparticles as carriers of natural products for the treatment of lung cancer. Conclusion: The use of nanoparticles allows the delivery of natural products, increasing their therapeutic properties against lung cancer cells, and decreasing the side effects of these highly toxic agents.

Keywords